A Study to Evaluate the Safety, Tolerability, Drug Levels, and Drug Effects of BMS-986326 in Participants With Atopic Dermatitis
Clinical trial NCT06248814 · COMPLETED
Trial details
- NCT number
- NCT06248814
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-03-06
- Primary completion
- 2025-11-06
- Enrollment
- 64
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.